The network point-of-care glucose testing market size is expected to reach USD 2,109.01 million by 2034, according to a new study by Polaris Market Research. The report “Network Point-of-Care Glucose Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, and CareSens Expert Plus), Modality, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Network point-of-care glucose testing refers to a system of connected glucose monitoring devices that enable real-time data sharing between patients and healthcare providers through cloud-based platforms or electronic health records (EHRs). The network point-of-care glucose testing market growth is attributed to the rising prevalence of diabetes, increasing demand for real-time monitoring, and advancements in digital healthcare integration.
A few key drivers propelling the network point-of-care glucose testing market demand are the rising adoption of continuous glucose monitoring (CGM) systems, technological innovations in wearable and handheld devices, and the need for remote patient management. Opportunities lie in emerging markets where diabetes cases are increasing, alongside the expansion of AI-driven analytics for predictive glucose monitoring. Trends such as noninvasive glucose testing, integration with mobile applications, and regulatory support for digital health solutions further support market expansion.
Network Point-of-Care Glucose Testing Market Report Highlights
The Accu-Chek Inform II segment, based on product, held the largest network point-of-care glucose testing market share in 2024 due to its widespread adoption in hospitals and clinical settings for accurate and rapid glucose testing.
North America held the largest share of the network point-of-care glucose testing market revenue in 2024 due to the high prevalence of diabetes, strong healthcare infrastructure, and advanced reimbursement policies.
Asia Pacific is the fastest-growing region, fueled by rising diabetes cases, increasing healthcare investments, and growing awareness of digital glucose monitoring solutions.
Several key players in the market are actively contributing to advancements in diabetes management. Abbott Laboratories has developed the FreeStyle Libre system, offering continuous glucose monitoring to patients. F. Hoffmann-La Roche Ltd. provides the Accu-Chek Inform II, a device designed for rapid and accurate blood glucose testing in clinical settings. Nova Biomedical offers the StatStrip Glucose Hospital Meter, known for its precision in point-of-care testing.
Polaris Market Research has segmented the network point-of-care glucose testing market report on the basis of product, modality, and region:
By Product Outlook (Revenue – USD Million, 2020–2034)
Accu-Chek Inform II
StatStrip
HemoCue
BAROzen H Expert Plus
i-STAT
CareSens Expert Plus
By Modality Outlook (Revenue – USD Million, 2020–2034)
Handheld/Portable Devices
Wearable Devices
Benchtop Devices
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Network Point-Of-Care Glucose Testing Market Insights
- 4.1. Network Point-Of-Care Glucose Testing Market – Market Snapshot
- 4.2. Network Point-Of-Care Glucose Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Diabetes
- 4.2.1.2. Technological Advancements in Glucose Monitoring
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Data security and interoperability issues
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Network Point-Of-Care Glucose Testing Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Network Point-Of-Care Glucose Testing Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 5.3. Accu-Chek Inform II
- 5.3.1. Global Network Point-Of-Care Glucose Testing Market, by Accu-Chek Inform II, by Region, 2020–2034 (USD Million)
- 5.4. StatStrip
- 5.4.1. Global Network Point-Of-Care Glucose Testing Market, by StatStrip, by Region, 2020–2034 (USD Million)
- 5.5. HemoCue
- 5.5.1. Global Network Point-Of-Care Glucose Testing Market, by HemoCue, by Region, 2020–2034 (USD Million)
- 5.6. BAROzen H Expert Plus
- 5.6.1. Global Network Point-Of-Care Glucose Testing Market, by BAROzen H Expert Plus, by Region, 2020–2034 (USD Million)
- 5.7. i-STAT
- 5.7.1. Global Network Point-Of-Care Glucose Testing Market, by i-STAT, by Region, 2020–2034 (USD Million)
- 5.8. CareSens Expert Plus
- 5.8.1. Global Network Point-Of-Care Glucose Testing Market, by CareSens Expert Plus, by Region, 2020–2034 (USD Million)
- 6. Global Network Point-Of-Care Glucose Testing Market, by Modality
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 6.3. Handheld/Portable Devices
- 6.3.1. Global Network Point-Of-Care Glucose Testing Market, by Handheld/Portable Devices, by Region, 2020–2034 (USD Million)
- 6.4. Wearable Devices
- 6.4.1. Global Network Point-Of-Care Glucose Testing Market, by Wearable Devices, by Region, 2020–2034 (USD Million)
- 6.5. Benchtop Devices
- 6.5.1. Global Network Point-Of-Care Glucose Testing Market, by Benchtop Devices, by Region, 2020–2034 (USD Million)
- 7. Global Network Point-Of-Care Glucose Testing Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Network Point-Of-Care Glucose Testing Market Assessment, By Geography, 2020–2034 (USD Million)
- 7.3. Network Point-Of-Care Glucose Testing Market – North America
- 7.3.1. North America: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.3.2. North America: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.3.3. Network Point-Of-Care Glucose Testing Market – U.S.
- 7.3.3.1. U.S.: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.3.3.2. U.S.: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.3.4. Network Point-Of-Care Glucose Testing Market – Canada
- 7.3.4.1. Canada: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.3.4.2. Canada: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4. Network Point-Of-Care Glucose Testing Market – Europe
- 7.4.1. Europe: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.2. Europe: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.3. Network Point-Of-Care Glucose Testing Market – UK
- 7.4.3.1. UK: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.3.2. UK: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.4. Network Point-Of-Care Glucose Testing Market – France
- 7.4.4.1. France: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.4.2. France: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.5. Network Point-Of-Care Glucose Testing Market – Germany
- 7.4.5.1. Germany: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.5.2. Germany: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.6. Network Point-Of-Care Glucose Testing Market – Italy
- 7.4.6.1. Italy: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.6.2. Italy: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.7. Network Point-Of-Care Glucose Testing Market – Spain
- 7.4.7.1. Spain: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.7.2. Spain: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.8. Network Point-Of-Care Glucose Testing Market – Netherlands
- 7.4.8.1. Netherlands: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.8.2. Netherlands: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.9. Network Point-Of-Care Glucose Testing Market – Russia
- 7.4.9.1. Russia: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.9.2. Russia: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.4.10. Network Point-Of-Care Glucose Testing Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.4.10.2. Rest of Europe: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5. Network Point-Of-Care Glucose Testing Market – Asia Pacific
- 7.5.1. Asia Pacific: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.2. Asia Pacific: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.3. Network Point-Of-Care Glucose Testing Market – China
- 7.5.3.1. China: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.3.2. China: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.4. Network Point-Of-Care Glucose Testing Market – India
- 7.5.4.1. India: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.4.2. India: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.5. Network Point-Of-Care Glucose Testing Market – Malaysia
- 7.5.5.1. Malaysia: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.5.2. Malaysia: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.6. Network Point-Of-Care Glucose Testing Market – Japan
- 7.5.6.1. Japan: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.6.2. Japan: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.7. Network Point-Of-Care Glucose Testing Market – Indonesia
- 7.5.7.1. Indonesia: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.7.2. Indonesia: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.8. Network Point-Of-Care Glucose Testing Market – South Korea
- 7.5.8.1. South Korea: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.8.2. South Korea: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.9. Network Point-Of-Care Glucose Testing Market – Australia
- 7.5.9.1. Australia: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.9.2. Australia: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.5.10. Network Point-Of-Care Glucose Testing Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.6. Network Point-Of-Care Glucose Testing Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.6.2. Middle East & Africa: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.6.3. Network Point-Of-Care Glucose Testing Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.6.3.2. Saudi Arabia: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.6.4. Network Point-Of-Care Glucose Testing Market – UAE
- 7.6.4.1. UAE: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.6.4.2. UAE: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.6.5. Network Point-Of-Care Glucose Testing Market – Israel
- 7.6.5.1. Israel: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.6.5.2. Israel: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.6.6. Network Point-Of-Care Glucose Testing Market – South Africa
- 7.6.6.1. South Africa: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.6.6.2. South Africa: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.6.7. Network Point-Of-Care Glucose Testing Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.7. Network Point-Of-Care Glucose Testing Market – Latin America
- 7.7.1. Latin America: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.7.2. Latin America: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.7.3. Network Point-Of-Care Glucose Testing Market – Mexico
- 7.7.3.1. Mexico: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.7.3.2. Mexico: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.7.4. Network Point-Of-Care Glucose Testing Market – Brazil
- 7.7.4.1. Brazil: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.7.4.2. Brazil: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.7.5. Network Point-Of-Care Glucose Testing Market – Argentina
- 7.7.5.1. Argentina: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.7.5.2. Argentina: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 7.7.6. Network Point-Of-Care Glucose Testing Market – Rest of Latin America
- 7.7.6.1. Rest of Latin America: Network Point-Of-Care Glucose Testing Market, by Product, 2020–2034 (USD Million)
- 7.7.6.2. Rest of Latin America: Network Point-Of-Care Glucose Testing Market, by Modality, 2020–2034 (USD Million)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. ACON Laboratories, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Abbott Laboratories
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. ARKRAY, Inc.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Ascensia Diabetes Care Holdings AG
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Danaher Corporation (HemoCue subsidiary)
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. DexCom, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. EKF Diagnostics Holdings plc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. F. Hoffmann-La Roche Ltd.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. LifeScan, Inc. (Platinum Equity Advisors, LLC subsidiary)
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Medtronic plc
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook